Periodic Reporting for period 2 - ITHACA (Digital Twin Technology to Predict Individual Response to Pharmacological Treatments in Ovarian Cancer)

High-grade serous ovarian cancer (HGSOC) is characterised by low 5-year survival (43%), high rates of recurrence, and frequent insurgence of drug resistance. Beside the terrible human cost of this disease, HGSOC has a substantial societal burden with excess costs estimated at...